DAN BAR ZOHAR;KOFLER DINA;NORA TARCIC;TEVA PHARMACEUTICAL INDUSTRIES LTD.
发明人:
DAN BAR ZOHAR,KOFLER DINA,NORA TARCIC
申请号：
IL25269917
公开号：
IL252699D0
申请日:
2017.06.06
申请国别(地区):
IL
年份:
2017
代理人:
摘要：
The subject invention provides for methods of reducing the relapse rate and/or reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient, the method comprising orally administering to the patient a daily dose of 0.6 mg laquinimod. The subject invention also provides for pharmaceutical oral unit dosage forms of 0.6 mg laquinimod for use in reducing the relapse rate and/or for use in reducing the accumulation of physical disability in a relapsing-remitting multiple sclerosis human patient.
